Skip to content

Axogen AXGN Cash ratio

Cash ratio at other companies

Baxter International logo
Baxter InternationalBAX
0.5×-0.1×
Stryker logo
StrykerSYK
0.5×+0.2×
IAR
Integra LifeSciencesIART
0.7×+0.4×
LeMaitre Vascular logo
LeMaitre VascularLMAT
0.8×-0.2×
Medtronic logo
MedtronicMDT
0.2×0.0×

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

Based on the most recent quarter.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's cash ratio?
Axogen (AXGN) reported cash ratio of 3.3× in Q1 2026.
How has Axogen's cash ratio changed year-over-year?
Axogen's cash ratio increased by 193.7% year-over-year, from 1.1× to 3.3×.
What is the long-term trend for Axogen's cash ratio?
Over 5 years (2020 to 2025), Axogen's cash ratio has grown at a -7.2% compound annual growth rate (CAGR), from 2.4× to 1.7×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.